Objectiu de la convocatòria

Infect-ERA is an ERA-NET on human infectious diseases.

With this fourth call, Infect-ERA aims to fund transnational and translational research, bringing together basic, applied and technology-driven research approaches of a broad variety of research topics regarding human infectious diseases (ID). This call enables multinational, collaborative research projects that address a specific topic of human ID research.

Two main research topics, which are equal in relevance for this call were identified:

The proposals should favourably a) show a close cooperation between academic and clinical and/or industrial participants, b) convincingly present the applications (exploitations) of the project results, and c) demonstrate a clear benefit to the public.

Característiques principals

Transnational research consortia are invited to submit proposals related with at least one of the following themes, which are equal in relevance for this call:

A) The host-pathogen interactions, with regard to clinically relevant microbial clones, focused on host susceptibility (e.g., innate immune response, populations at risk, etc.).

B) Development of innovative strategies for the diagnostic and treatment of high clinically relevant microbial infections; optimisation of antimicrobial therapy in an individual patient and development of biomarkers to allow individual response prediction.

To address the above two topics the proposals could contemplate:

- Identification of host factors that define host susceptibility in regards to infection, disease progression and transmissibility.

- Differences in susceptibility to infections between individuals or inadequate response to infections and/or treatments.

- Host molecular mechanisms that define the competence of the pathogen.

- Development of innovative strategies for the diagnostic and treatment of microbial infections for personalised treatments.

- Identification of biomarkers based on the host-pathogen interaction that allow individual response prediction to shorten antimicrobial treatment courses.

- Identification of rare mutations associated with host susceptibility.

- Individual differences in response to vaccination.

- Development of innovative antimicrobial strategies focused on exploiting the host immune response.

- Development of new methods for rapid determination of drug levels and/or microbial burden, at different body sites and in different bodily fluids, to optimize antimicrobial therapy in an individual patient.

Proposals with topics HIV/AIDS, malaria and tuberculosis are not in the scope of the call.

The following countries are involved: Austria, Belgium, France, Germany, Hungary, India, Israel, Italy, Poland, Portugal, Romania and Spain.

Convocatòria (URL)

http://www.infect-era.eu/4th-call-2016

Requisits

Only transnational projects will be funded, with a maximum of six participants from a minimum of three countries participating in this third call, should favourably include participants from academia and clinics and/or industry.

A portion of the total funding is reserved to support projects of young scientists' consortia and networking amongst these.

Please see the Guidelines for Applicants for the list of funding organisations.

Applicants must refer and adhere to the specific regulations of the national funding organisations. Each project partner is responsible for ensuring that he/she meets the national eligibility criteria. Therefore each project partner is strongly encouraged to get in touch with his/her National Contact. The National Regulations of each partner country are described in section  of the Guidelines for Applicants.

Dotació

For Spanish participants:

€ 150.000 for Project partners

€ 200.000 for Project coordinators

(in case of the centres formed by more than one Spanish legal entities, the maximum funding should not exceed 150 K€ per project (centros mixtos CSIC)

Durada

3 years.

In case of interest, please contact the Research Support Office

(Leonor Norton: lnorton@fsjd.org, recerca@fsjd.org)